INSIGHTS &
INDUSTRY NEWS

Buyer interest in private duty home care is returning, backed by new platform investment and a tougher environment for government-funded deals. Cory Mertz explains what's driving the shift and what it means for agency owners considering a sale.

Running on EOS® builds a better business, but is it a more valuable one? How to connect Rocks, Issues, and the Scorecard to enterprise value before a sale.

What healthcare owners can expect during M&A due diligence: when it starts, what buyers review, the quality of earnings process, and how to keep a deal on track.

What healthcare owners should understand before signing a letter of intent: exclusivity, deal structure, re-trade risk, and certainty to close.

Thinking of selling your home health, hospice, or home care agency in 2026? How the CMS moratorium, 36-month rule, and fraud crackdown affect your sale.

Not every healthcare transaction calls for the same advisor. Learn the difference between a business broker, M&A advisor, and investment banker before deciding who should represent your business.

Selling an addiction treatment center involves more than financials, buyer interest, and timing. Trust between buyer and seller is the variable that most often determines whether a transaction closes, and on what terms. Knowing what questions to ask, and understanding what the buyer needs from you in return, can be the difference between a successful exit and a deal that falls apart in due diligence.